Moleculin Biotech (NasdaqCM:MBRX) FY Conference March 24, 2026 03:00 PM ET Company ParticipantsWalter Klemp - Founder, Chairman, and CEOConference Call ParticipantsJonathan Aschoff - Senior Biotechnology AnalystJonathan AschoffWelcome back. This is Jonathan Aschoff, senior biotechnology analyst at Roth Capital Partners. Who we have now is Walter Klemp, the CEO of Moleculin Biotech.Walter KlempHey, Jonathan.Jonathan AschoffUm-Walter KlempThanks for having me.Jonathan AschoffYou're very welcome, Wally. You kn ...